Actively Recruiting
Prospective Biobanking Study in Cancer Patients Aiming at Better Understand the Link Between the Molecular Alterations of the Tumor Itself, Its Microenvironment and Immune Response (SCANDARE)
Led by Institut Curie · Updated on 2026-02-03
1050
Participants Needed
6
Research Sites
782 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
SCANDARE is a prospective biobanking study on tumor (+/- nodes), plasma and blood samples at different time points in ovarian, triple negative breast, Head and Neck Cancer, advanced stage treatment-naïve cervical or vulva cancer and sarcoma (breast angiosarcoma and uterine sarcoma) cancers. This study will allowed to identify new molecular and/or immunological biomarkers associated with clinical and biological features of the tumors. All patients will receive standard treatment according to the stage of the diseases and usual procédures.
CONDITIONS
Official Title
Prospective Biobanking Study in Cancer Patients Aiming at Better Understand the Link Between the Molecular Alterations of the Tumor Itself, Its Microenvironment and Immune Response (SCANDARE)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Newly diagnosed treatment-nafve ovarian cancer patients eligible for surgery or neoadjuvant chemotherapy
- Newly diagnosed treatment-nafve triple-negative breast cancer patients eligible for surgery or neoadjuvant chemotherapy
- Newly diagnosed treatment-nafve head and neck cancer patients eligible for surgery
- Newly diagnosed treatment-nafve vulva cancer or cervical cancer patients with stage Ia - IIa1 with nodal metastasis, postoperative positive margin or parametrial-vaginal involvement, or stage 61IIa2
- Newly diagnosed treatment-nafve sarcoma cancer patients with breast angiosarcoma or uterine sarcoma eligible for surgery or systemic treatment
- Male or female patients 18 years of age or older
- Signed informed consent
You will not qualify if you...
- Patients younger than 18 years old
- Patients with psychological, familial, sociological, or geographical conditions that may prevent following the study protocol and follow-up
- Patients deprived of liberty or under legal guardianship
- Patients not affiliated with the Social Security System
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 6 locations
1
Institut Bergonie
Bordeaux, France, 33076
Actively Recruiting
2
Centre Oscar Lambret
Lille, France, 59000
Actively Recruiting
3
Centre Leon Berard
Lyon, France, 69373
Actively Recruiting
4
Institut Curie
Paris, France, 75005
Actively Recruiting
5
Institut Curie Hopital Rene Huguenin
Saint-Cloud, France, 92210
Actively Recruiting
6
Institut de Cancérologie de Lorraine - Nancy
Vandœuvre-lès-Nancy, France
Not Yet Recruiting
Research Team
A
Anne-Sophie PLISSONNIER
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
BASIC_SCIENCE
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here